Who owns LANTERN PHARMA INC?
- Ticker: LTRN
- CUSIP Number: 51654w101
Tip: Access positions for across all investors
Analyze quarterly positions in Lantern Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Lantern Pharma stock
Who bought or sold LANTERN PHARMA INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 365k | $1.6M | -1% | Dec 2023 |
|
CM Management | 80k | $342k | 7% | Dec 2023 |
|
Commonwealth Equity Services | 59k | $252k | 283% | Dec 2023 |
|
Redmond Asset Management | 41k | $174k | -13% | Dec 2023 |
|
Horizon Kinetics Asset Management | 29k | $123k | -4% | Dec 2023 |
|
Bank of New York Mellon | 27k | $113k | 0% | Dec 2023 |
|
UBS Group | 26k | $111k | -4% | Dec 2023 |
|
Citadel Advisors | 26k | $109k | -36% | Dec 2023 |
|
Pathway Financial Advisors | 25k | $220k | -12% | Mar 2024 |
|
Meridian Wealth Management | 20k | $84k | 18% | Dec 2023 |
|
Sigma Planning | 12k | $51k | -34% | Dec 2023 |
|
Dimensional Fund Advisors | 12k | $51k | 100% | Dec 2023 |
|
Wells Fargo & Company | 4.5k | $19k | 0% | Dec 2023 |
|
Indiana Trust & Investment Management | 750.00 | $6.6k | 100% | Mar 2024 |
|
Wolff Wiese Magana | 600.00 | $5.3k | 0% | Mar 2024 |
|
Rhumbline Advisers | 228.00 | $974.996400 | 0% | Dec 2023 |
|
Advisor Group Holdings | 200.00 | $856.000000 | 0% | Dec 2023 |
|
Hanson McClain Advisors | 100.00 | $428.000000 | 0% | Dec 2023 |
|
Royal Bank of Canada | 86.00 | $0 | -19% | Dec 2023 |
|
Jpmorgan Chase & Co | 13.00 | $56.000100 | 44% | Dec 2023 |
|
Bank of America Corporation | 5.00 | $21.000000 | 100% | Dec 2023 |
|